Herpes NOS
Gilead’s $35M Herpes Deal with Assembly Biosciences and Recent FDA Approvals
Gilead; Assembly Biosciences; herpes; HSV; ABI-1179; ABI-5366; FDA; Boehringer; Roche
Actionable Insights Powered by AI
Gilead; Assembly Biosciences; herpes; HSV; ABI-1179; ABI-5366; FDA; Boehringer; Roche